Characterization of lead compounds targeting the selenoprotein thioredoxin glutathione reductase for treatment of schistosomiasis

Schistosomiasis is a widespread human parasitic disease currently affecting over 200 million people. Chemotherapy for schistosomiasis relies exclusively on praziquantel. Although significant advances have been made in recent years to reduce the incidence and intensity of schistosome infections, thes...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:ACS Infect Dis
Egile Nagusiak: Lyu, Haining, Petukhov, Pavel A., Banta, Paul R., Jadhav, Ajit, Lea, Wendy A., Cheng, Qing, Arnér, Elias S. J., Simeonov, Anton, Thatcher, Gregory R. J., Angelucci, Francesco, Williams, David L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072008/
https://ncbi.nlm.nih.gov/pubmed/31939288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.9b00354
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak